Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 148.6B | 139.5B | 140.9B | 76.7B |
Cost of revenue | 120.1B | 107.1B | 112.9B | 50.8B |
Gross profit | 28.5B | 32.3B | 28.0B | 25.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 845.5M | 933.1M | 675.6M | 650M |
Other operating expenses | 4.1B | 3.7B | 3.5B | 3.3B |
Operating income | 15.2B | 19.7B | 16.8B | 15.8B |
Non operating interest income | ||||
Income | 1.9B | 1.5B | 1.2B | 536.6M |
Expense | 73.9M | 68.1M | 86.9M | 114.6M |
Other income expense | — | — | — | — |
Pretax income | 21.8B | 25.4B | 21.2B | 19.5B |
Tax provision | 4.7B | 5.6B | 4.8B | 4.5B |
Net income | 17.1B | 19.8B | 16.4B | 15.0B |
Basic EPS | 12.3 | 28.4 | 23.4 | 21.5 |
Diluted EPS | 12.3 | 28.4 | 23.4 | 21.5 |
Basic average shares | 1.4B | 700M | 700M | 700M |
Diluted average shares | 1.4B | 700M | 700M | 700M |
EBITDA | 25.8B | 29.0B | 24.3B | 22.2B |
Net income from continuing op. | 21.8B | 25.4B | 21.2B | 19.5B |
Minority interests | 47.5M | 16.7M | 0 | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |